Kymab Presents Updates at the American Society of Hematology (ASH) 61st Annual Meeting and Exposition
Kymab Presents Updates at the American Society of Hematology (ASH) 61st Annual Meeting and Exposition Cambridge, UK; December 6, 2019: Kymab, a clinical-stage biopharmaceutical company developing monoclonal and bispecific antibody-based therapeutics, today …